Dynavax Technologies CorporationLease Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations
The following is summary of a Lease Agreement (“Lease Agreement”) for 9 and 11 Eichsfelder Strasse, Düsseldorf dates as of August 14, 1990, as amended. The Lease Agreement is in German and this summary in English is provided pursuant to Rule 12b-12(d)(3).
ContractShare Sale and Purchase Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • London
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
ContractDefinitive Commercial Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • London
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
ContractWarrant Purchase Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • Delaware
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations
This Exclusive License Agreement (“Agreement”) is made as of the 21st day of April 2006 (hereinafter the “Effective Date”) by and between
NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT dated as of April 18, 2006 among DYNAVAX TECHNOLOGIES CORPORATION, SYMPHONY DYNAMO, INC. and SYMPHONY DYNAMO HOLDINGS LLCTechnology License Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and effective as of April 18, 2006 by and among, Dynavax Technologies Corporation, a Delaware corporation (the “Licensor”), Symphony Dynamo, Inc., a Delaware corporation (“Symphony Dynamo”) (each of Licensor and Symphony Dynamo, Inc. being a “Party,” and collectively, the “Parties”), and Symphony Dynamo Holdings LLC, a Delaware limited liability company (“Holdings”).
ContractPurchase Option Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • Delaware
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • Washington
This License and Supply Agreement (this “Agreement”) is entered into as of February 28th, 2002 (the “Effective Date”) by and between Corixa Corporation, a Delaware corporation having offices at 1124 Columbia Street, Suite 200, Seattle, Washington 98104, USA and its Affiliates (“Corixa”), and Rhein Biotech N.V. having offices at Gaetano Martinolaan 95, 6229 GS Maastricht, The Netherlands and its Affiliates, a Netherlands corporation (“Rhein”).
AMENDED AND RESTATED RESEARCH AND DEVELOPMENT AGREEMENT among DYNAVAX TECHNOLOGIES CORPORATION, SYMPHONY DYNAMO HOLDINGS LLC, and SYMPHONY DYNAMO, INC. Dated as of April 18, 2006Research and Development Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • New York
This AMENDED AND RESTATED RESEARCH AND DEVELOPMENT AGREEMENT (this “Agreement”) is entered into as of April 18, 2006 (the “Closing Date”), by and among DYNAVAX TECHNOLOGIES CORPORATION, a Delaware corporation (“Dynavax”), SYMPHONY DYNAMO, INC., a Delaware corporation (“Symphony Dynamo”) (each of Dynavax and Symphony Dynamo being a “Party,” and collectively, the “Parties”), and SYMPHONY DYNAMO HOLDINGS LLC, a Delaware limited liability company (“Holdings”) (which shall be a Party to this Agreement solely with respect to Articles 1, 11 and 14, and Sections 5.2, 5.3, 6.3, 6.4, 6.7 and 7.5). Capitalized terms used herein and not defined herein shall have the meanings assigned to such terms in Annex A attached hereto.
ContractRegistration Rights Agreement • August 4th, 2006 • Dynavax Technologies Corp • Pharmaceutical preparations • Delaware
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
